Published June 2015 | Version v1
Miscellaneous Restricted

Role and liabilities of the medical physicist in the validation of oncologic treatments in internal vectorized radiation therapy. S.F.P.M. report nr 31, June 2015

  • 1. CHU La Timone, AP-HM, Marseille (France)
  • 2. CHU Lyon Sud, HCL, Lyon (France)
  • 3. CHU Saint-Louis, AP-HP, Paris (France)
  • 4. Centre Georges-Francois Leclerc, Dijon (France)
  • 5. Centre Henri Becquerel, Rouen (France)
  • 6. CHU Beaujon, AP-HP, Clichy (France)
  • 7. Clinique de l'Europe, Amiens (France)
  • 8. INSERM, Toulouse (France)
  • 9. Centre Eugene Marquis, Rennes (France)
  • 10. Institut du Cancer, Montpellier (France)
  • 11. Societe Francaise de Physique Medicale - SFPM, Centre Antoine Beclere, 45, rue des Saints Peres, 75270 Paris Cedex 06 (France)

Description

According to legal arrangements and decrees, the medical physicist must validate the preparation of each treatment based on the use of radio-elements in non-sealed sources. As the medical physicist is therefore liable of this validation, this report addresses the approach to be followed to comply with the law. The authors first outline that this report only concerns oncologic internal vectorized radiation therapy, and does not address the dosimetric aspect of these treatments. After having recalled the principles of internal vectorized radiography, they describe the role of the different actors: nuclear physician, medical physicist, radio-pharmacist, radio-pharmacy dispenser, medical electro-radiology operator, state nurse. They address the various aspects of the process of validation of a treatment preparation: technical prerequisites, organisational prerequisite, validation process, traceability, dosimetry. Several examples are proposed in appendix regarding traceability, dosimetry software, examples of PRM files

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Additional details

Additional titles

Original title (French)
Le role et les responsabilites du physicien medical dans la validation des traitements oncologiques en radiotherapie interne vectorisee. Rapport S.F.P.M. no. 31, Juin 2015

Publishing Information

Imprint Pagination
44 p.
Report number
INIS-FR--17-0685

Optional Information

Notes
12 refs.; Available from the INIS Liaison Officer for France, see the 'INIS contacts' section of the INIS website for current contact and E-mail addresses: http://www.iaea.org/inis/Contacts/